$ cat ./records/gates-foundation-awarded-iom-a-grant-for-health-programs-serving--2023.txt
Gates Foundation awarded IOM a grant for health programs serving mobile and displaced populations in southern Afghanistan
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation awarded the International Organization for Migration (IOM) a grant to enhance community immunity and essential health service access in southern Afghanistan, with a specific focus on high-risk mobile populations — including internally displaced families and nomadic communities — who fall outside the reach of fixed health facilities. The program aimed to vaccinate 75 percent of children under five against polio in targeted high-mobility communities in Southern Afghanistan, where ongoing insecurity and population movement had created persistent gaps in vaccination coverage. It represented the Gates Foundation's recognition of IDPs and mobile populations as a distinct and chronically underserved health group.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Invests $40 Million to Scale mRNA Vaccine Manufacturing in Africa
Next →
Gates Foundation and UNHCR published global best-practice guidelines for sustainable refugee camp sanitation
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.